![To save pharmacists' time a RTEC is being tested in Britain](assets/cache/images/mirovye-novosti/4569-400x400-b0d.jpg)
Department of the National Health Service of UK in association with the NHS Business Services Authority have developed RTEC based drug dispensing platform.
![The effectiveness of an anticoagulant in stroke has been proven](assets/cache/images/mirovye-novosti/mirovye-novosti-3/236-400x400-71d.jpg)
The FDA has approved the anticoagulant Brilinta for use in patients with cardiovascular disease.
![The drug for amyotrophic lateral sclerosis has impressed neurologists](assets/cache/images/mirovye-novosti/mirovye-novosti-3/123-400x400-4b6.jpg)
In a small study, a biotech company has tested its own amyotrophic lateral sclerosis drug.
![Osteoporosis - From Idea to Action. Zoleum.](assets/cache/images/deit-dobavki/zoleum-box-400x400-695.jpg)
On 22nd of September 2020 the company "Ananta Medicare" in association with "Clinic of modern rheumatology" held the first webinar on the topic of osteoporosis. The lecture "Osteoporosis - from idea to action" was conducted by prof. Egudina Elizaveta Davydovna.
![Swiss company is interested in finding new drug targets](assets/cache/images/mirovye-novosti/mirovye-novosti-2/roche_thumb-400x400-c03.jpg)
Scenic Biotech founders and biologists have designed their own functional genomics platform to accurately identify genes that modify a specific disease.
![New effective drug for Cushing's syndrome](assets/cache/images/mirovye-novosti/mirovye-novosti-2/razrabotka-400x400-f03.jpg)
The steroidogenesis inhibitor levoketoconazole has improved laboratory parameters in adult patients with endogenous Cushing's disease.
![The World Health Organization expects to receive at least 2 billion doses of COVID-19 vaccines next year](assets/cache/images/mirovye-novosti/mirovye-novosti-2/lgblq-400x400-d39.jpg)
The World Health Organization expects to receive 2 billion doses of COVID-19 vaccines under the COVAX program in 2021.
![GALAPAGOS and GILEAD have demonstrated victory over scleroderma](assets/cache/images/mirovye-novosti/mirovye-novosti-2/images-1-400x400-b88.jpg)
Experts believe that GALAPAGOS and GILEAD have managed to make a breakthrough on an experimental autotoxin inhibitor in the field of scleroderma therapy.
![VIR Biotechnology has demonstrated a new effective drug for hepatitis B prevention](assets/cache/images/mirovye-novosti/mirovye-novosti-2/579085ea-f7ed-407a-b22d-e29083f43430-400x400-704.jpg)
Clinical studies on VIR-2218 have shown an effective result in the fight against hepatitis B.
![Orphan drug status has been assigned to new glioblastoma drug](assets/cache/images/mirovye-novosti/mirovye-novosti-2/1253-400x400-010.jpg)
The FDA has assigned an orphan drug status to a drug based on rhenium nanoliposom.